|
|||||||
| |||||||
| |||||||
1 | AN ACT concerning professional regulation.
| ||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||
3 | represented in the General Assembly:
| ||||||
4 | Section 5. The Pharmacy Practice Act is amended by changing | ||||||
5 | Sections 3, 9, and 25.15 and by adding Section 8.5 as follows:
| ||||||
6 | (225 ILCS 85/3) (from Ch. 111, par. 4123)
| ||||||
7 | (Section scheduled to be repealed on January 1, 2018)
| ||||||
8 | Sec. 3. Definitions. For the purpose of this Act, except | ||||||
9 | where otherwise
limited therein:
| ||||||
10 | (a) "Pharmacy" or "drugstore" means and includes every | ||||||
11 | store, shop,
pharmacy department, or other place where | ||||||
12 | pharmacist
care is
provided
by a pharmacist (1) where drugs, | ||||||
13 | medicines, or poisons are
dispensed, sold or
offered for sale | ||||||
14 | at retail, or displayed for sale at retail; or
(2)
where
| ||||||
15 | prescriptions of physicians, dentists, advanced practice | ||||||
16 | nurses, physician assistants, veterinarians, podiatrists, or
| ||||||
17 | optometrists, within the limits of their
licenses, are
| ||||||
18 | compounded, filled, or dispensed; or (3) which has upon it or
| ||||||
19 | displayed within
it, or affixed to or used in connection with | ||||||
20 | it, a sign bearing the word or
words "Pharmacist", "Druggist", | ||||||
21 | "Pharmacy", "Pharmaceutical
Care", "Apothecary", "Drugstore",
| ||||||
22 | "Medicine Store", "Prescriptions", "Drugs", "Dispensary", | ||||||
23 | "Medicines", or any word
or words of similar or like import, |
| |||||||
| |||||||
1 | either in the English language
or any other language; or (4) | ||||||
2 | where the characteristic prescription
sign (Rx) or similar | ||||||
3 | design is exhibited; or (5) any store, or
shop,
or other place | ||||||
4 | with respect to which any of the above words, objects,
signs or | ||||||
5 | designs are used in any advertisement.
| ||||||
6 | (b) "Drugs" means and includes (l) articles recognized
in | ||||||
7 | the official United States Pharmacopoeia/National Formulary | ||||||
8 | (USP/NF),
or any supplement thereto and being intended for and | ||||||
9 | having for their
main use the diagnosis, cure, mitigation, | ||||||
10 | treatment or prevention of
disease in man or other animals, as | ||||||
11 | approved by the United States Food and
Drug Administration, but | ||||||
12 | does not include devices or their components, parts,
or | ||||||
13 | accessories; and (2) all other articles intended
for and having | ||||||
14 | for their main use the diagnosis, cure, mitigation,
treatment | ||||||
15 | or prevention of disease in man or other animals, as approved
| ||||||
16 | by the United States Food and Drug Administration, but does not | ||||||
17 | include
devices or their components, parts, or accessories; and | ||||||
18 | (3) articles
(other than food) having for their main use and | ||||||
19 | intended
to affect the structure or any function of the body of | ||||||
20 | man or other
animals; and (4) articles having for their main | ||||||
21 | use and intended
for use as a component or any articles | ||||||
22 | specified in clause (l), (2)
or (3); but does not include | ||||||
23 | devices or their components, parts or
accessories.
| ||||||
24 | (c) "Medicines" means and includes all drugs intended for
| ||||||
25 | human or veterinary use approved by the United States Food and | ||||||
26 | Drug
Administration.
|
| |||||||
| |||||||
1 | (d) "Practice of pharmacy" means (1) the interpretation and | ||||||
2 | the provision of assistance in the monitoring, evaluation, and | ||||||
3 | implementation of prescription drug orders; (2) the dispensing | ||||||
4 | of prescription drug orders; (3) participation in drug and | ||||||
5 | device selection; (4) drug administration limited to the | ||||||
6 | administration of oral, topical, injectable, and inhalation as | ||||||
7 | follows: in the context of patient education on the proper use | ||||||
8 | or delivery of medications; vaccination of patients 14 years of | ||||||
9 | age and older pursuant to a valid prescription or standing | ||||||
10 | order, by a physician licensed to practice medicine in all its | ||||||
11 | branches, upon completion of appropriate training, including | ||||||
12 | how to address contraindications and adverse reactions set | ||||||
13 | forth by rule, with notification to the patient's physician and | ||||||
14 | appropriate record retention, or pursuant to hospital pharmacy | ||||||
15 | and therapeutics committee policies and procedures; (5) drug | ||||||
16 | regimen review; (6) drug or drug-related research; (7) the | ||||||
17 | provision of patient counseling; (8) the practice of | ||||||
18 | telepharmacy; (9) the provision of those acts or services | ||||||
19 | necessary to provide pharmacist care; (10) medication therapy | ||||||
20 | management; and (11) the responsibility for compounding and | ||||||
21 | labeling of drugs and devices (except labeling by a | ||||||
22 | manufacturer, repackager, or distributor of non-prescription | ||||||
23 | drugs and commercially packaged legend drugs and devices), | ||||||
24 | proper and safe storage of drugs and devices, and maintenance | ||||||
25 | of required records. A pharmacist who performs any of the acts | ||||||
26 | defined as the practice of pharmacy in this State must be |
| |||||||
| |||||||
1 | actively licensed as a pharmacist under this Act.
| ||||||
2 | (e) "Prescription" means and includes any written, oral, | ||||||
3 | facsimile, or
electronically transmitted order for drugs
or | ||||||
4 | medical devices, issued by a physician licensed to practice | ||||||
5 | medicine in
all its branches, dentist, veterinarian, or | ||||||
6 | podiatrist, or
optometrist, within the
limits of their | ||||||
7 | licenses, by a physician assistant in accordance with
| ||||||
8 | subsection (f) of Section 4, or by an advanced practice nurse | ||||||
9 | in
accordance with subsection (g) of Section 4, containing the
| ||||||
10 | following: (l) name
of the patient; (2) date when prescription | ||||||
11 | was issued; (3) name
and strength of drug or description of the | ||||||
12 | medical device prescribed;
and (4) quantity, (5) directions for | ||||||
13 | use, (6) prescriber's name,
address
and signature, and (7) DEA | ||||||
14 | number where required, for controlled
substances.
DEA numbers | ||||||
15 | shall not be required on inpatient drug orders.
| ||||||
16 | (f) "Person" means and includes a natural person, | ||||||
17 | copartnership,
association, corporation, government entity, or | ||||||
18 | any other legal
entity.
| ||||||
19 | (g) "Department" means the Department of Financial and
| ||||||
20 | Professional Regulation.
| ||||||
21 | (h) "Board of Pharmacy" or "Board" means the State Board
of | ||||||
22 | Pharmacy of the Department of Financial and Professional | ||||||
23 | Regulation.
| ||||||
24 | (i) "Secretary"
means the Secretary
of Financial and | ||||||
25 | Professional Regulation.
| ||||||
26 | (j) "Drug product selection" means the interchange for a
|
| |||||||
| |||||||
1 | prescribed pharmaceutical product in accordance with Section | ||||||
2 | 25 of
this Act and Section 3.14 of the Illinois Food, Drug and | ||||||
3 | Cosmetic Act.
| ||||||
4 | (k) "Inpatient drug order" means an order issued by an | ||||||
5 | authorized
prescriber for a resident or patient of a facility | ||||||
6 | licensed under the
Nursing Home Care Act or the Hospital | ||||||
7 | Licensing Act, or "An Act in relation to
the founding and | ||||||
8 | operation of the University of Illinois Hospital and the
| ||||||
9 | conduct of University of Illinois health care programs", | ||||||
10 | approved July 3, 1931,
as amended, or a facility which is | ||||||
11 | operated by the Department of Human
Services (as successor to | ||||||
12 | the Department of Mental Health
and Developmental | ||||||
13 | Disabilities) or the Department of Corrections.
| ||||||
14 | (k-5) "Pharmacist" means an individual health care | ||||||
15 | professional and
provider currently licensed by this State to | ||||||
16 | engage in the practice of
pharmacy.
| ||||||
17 | (l) "Pharmacist in charge" means the licensed pharmacist | ||||||
18 | whose name appears
on a pharmacy license and who is responsible | ||||||
19 | for all aspects of the
operation related to the practice of | ||||||
20 | pharmacy.
| ||||||
21 | (m) "Dispense" or "dispensing" means the interpretation, | ||||||
22 | evaluation, and implementation of a prescription drug order, | ||||||
23 | including the preparation and delivery of a drug or device to a | ||||||
24 | patient or patient's agent in a suitable container | ||||||
25 | appropriately labeled for subsequent administration to or use | ||||||
26 | by a patient in accordance with applicable State and federal |
| |||||||
| |||||||
1 | laws and regulations.
"Dispense" or "dispensing" does not mean | ||||||
2 | the physical delivery to a patient or a
patient's | ||||||
3 | representative in a home or institution by a designee of a | ||||||
4 | pharmacist
or by common carrier. "Dispense" or "dispensing" | ||||||
5 | also does not mean the physical delivery
of a drug or medical | ||||||
6 | device to a patient or patient's representative by a
| ||||||
7 | pharmacist's designee within a pharmacy or drugstore while the | ||||||
8 | pharmacist is
on duty and the pharmacy is open.
| ||||||
9 | (n) "Nonresident pharmacy"
means a pharmacy that is located | ||||||
10 | in a state, commonwealth, or territory
of the United States, | ||||||
11 | other than Illinois, that delivers, dispenses, or
distributes, | ||||||
12 | through the United States Postal Service, commercially | ||||||
13 | acceptable parcel delivery service, or other common
carrier, to | ||||||
14 | Illinois residents, any substance which requires a | ||||||
15 | prescription.
| ||||||
16 | (o) "Compounding" means the preparation and mixing of | ||||||
17 | components, excluding flavorings, (1) as the result of a | ||||||
18 | prescriber's prescription drug order or initiative based on the | ||||||
19 | prescriber-patient-pharmacist relationship in the course of | ||||||
20 | professional practice or (2) for the purpose of, or incident | ||||||
21 | to, research, teaching, or chemical analysis and not for sale | ||||||
22 | or dispensing. "Compounding" includes the preparation of drugs | ||||||
23 | or devices in anticipation of receiving prescription drug | ||||||
24 | orders based on routine, regularly observed dispensing | ||||||
25 | patterns. Commercially available products may be compounded | ||||||
26 | for dispensing to individual patients only if all of the |
| |||||||
| |||||||
1 | following conditions are met: (i) the commercial product is not | ||||||
2 | reasonably available from normal distribution channels in a | ||||||
3 | timely manner to meet the patient's needs and (ii) the | ||||||
4 | prescribing practitioner has requested that the drug be | ||||||
5 | compounded.
| ||||||
6 | (p) (Blank).
| ||||||
7 | (q) (Blank).
| ||||||
8 | (r) "Patient counseling" means the communication between a | ||||||
9 | pharmacist or a student pharmacist pharmacy intern under the | ||||||
10 | supervision of a pharmacist and a patient or the patient's | ||||||
11 | representative about the patient's medication or device for the | ||||||
12 | purpose of optimizing proper use of prescription medications or | ||||||
13 | devices. "Patient counseling" may include without limitation | ||||||
14 | (1) obtaining a medication history; (2) acquiring a patient's | ||||||
15 | allergies and health conditions; (3) facilitation of the | ||||||
16 | patient's understanding of the intended use of the medication; | ||||||
17 | (4) proper directions for use; (5) significant potential | ||||||
18 | adverse events; (6) potential food-drug interactions; and (7) | ||||||
19 | the need to be compliant with the medication therapy. A | ||||||
20 | pharmacy technician may only participate in the following | ||||||
21 | aspects of patient counseling under the supervision of a | ||||||
22 | pharmacist: (1) obtaining medication history; (2) providing | ||||||
23 | the offer for counseling by a pharmacist or student pharmacist | ||||||
24 | intern ; and (3) acquiring a patient's allergies and health | ||||||
25 | conditions.
| ||||||
26 | (s) "Patient profiles" or "patient drug therapy record" |
| |||||||
| |||||||
1 | means the
obtaining, recording, and maintenance of patient | ||||||
2 | prescription
information, including prescriptions for | ||||||
3 | controlled substances, and
personal information.
| ||||||
4 | (t) (Blank).
| ||||||
5 | (u) "Medical device" means an instrument, apparatus, | ||||||
6 | implement, machine,
contrivance, implant, in vitro reagent, or | ||||||
7 | other similar or related article,
including any component part | ||||||
8 | or accessory, required under federal law to
bear the label | ||||||
9 | "Caution: Federal law requires dispensing by or on the order
of | ||||||
10 | a physician". A seller of goods and services who, only for the | ||||||
11 | purpose of
retail sales, compounds, sells, rents, or leases | ||||||
12 | medical devices shall not,
by reasons thereof, be required to | ||||||
13 | be a licensed pharmacy.
| ||||||
14 | (v) "Unique identifier" means an electronic signature, | ||||||
15 | handwritten
signature or initials, thumb print, or other | ||||||
16 | acceptable biometric
or electronic identification process as | ||||||
17 | approved by the Department.
| ||||||
18 | (w) "Current usual and customary retail price" means the | ||||||
19 | price that a pharmacy charges to a non-third-party payor
.
| ||||||
20 | (x) "Automated pharmacy system" means a mechanical system | ||||||
21 | located within the confines of the pharmacy or remote location | ||||||
22 | that performs operations or activities, other than compounding | ||||||
23 | or administration, relative to storage, packaging, dispensing, | ||||||
24 | or distribution of medication, and which collects, controls, | ||||||
25 | and maintains all transaction information. | ||||||
26 | (y) "Drug regimen review" means and includes the evaluation |
| |||||||
| |||||||
1 | of prescription drug orders and patient records for (1)
known | ||||||
2 | allergies; (2) drug or potential therapy contraindications;
| ||||||
3 | (3) reasonable dose, duration of use, and route of | ||||||
4 | administration, taking into consideration factors such as age, | ||||||
5 | gender, and contraindications; (4) reasonable directions for | ||||||
6 | use; (5) potential or actual adverse drug reactions; (6) | ||||||
7 | drug-drug interactions; (7) drug-food interactions; (8) | ||||||
8 | drug-disease contraindications; (9) therapeutic duplication; | ||||||
9 | (10) patient laboratory values when authorized and available; | ||||||
10 | (11) proper utilization (including over or under utilization) | ||||||
11 | and optimum therapeutic outcomes; and (12) abuse and misuse.
| ||||||
12 | (z) "Electronic transmission prescription" means any | ||||||
13 | prescription order for which a facsimile or electronic image of | ||||||
14 | the order is electronically transmitted from a licensed | ||||||
15 | prescriber to a pharmacy. "Electronic transmission | ||||||
16 | prescription" includes both data and image prescriptions.
| ||||||
17 | (aa) "Medication therapy management services" means a | ||||||
18 | distinct service or group of services offered by licensed | ||||||
19 | pharmacists, physicians licensed to practice medicine in all | ||||||
20 | its branches, advanced practice nurses authorized in a written | ||||||
21 | agreement with a physician licensed to practice medicine in all | ||||||
22 | its branches, or physician assistants authorized in guidelines | ||||||
23 | by a supervising physician that optimize therapeutic outcomes | ||||||
24 | for individual patients through improved medication use. In a | ||||||
25 | retail or other non-hospital pharmacy, medication therapy | ||||||
26 | management services shall consist of the evaluation of |
| |||||||
| |||||||
1 | prescription drug orders and patient medication records to | ||||||
2 | resolve conflicts with the following: | ||||||
3 | (1) known allergies; | ||||||
4 | (2) drug or potential therapy contraindications; | ||||||
5 | (3) reasonable dose, duration of use, and route of | ||||||
6 | administration, taking into consideration factors such as | ||||||
7 | age, gender, and contraindications; | ||||||
8 | (4) reasonable directions for use; | ||||||
9 | (5) potential or actual adverse drug reactions; | ||||||
10 | (6) drug-drug interactions; | ||||||
11 | (7) drug-food interactions; | ||||||
12 | (8) drug-disease contraindications; | ||||||
13 | (9) identification of therapeutic duplication; | ||||||
14 | (10) patient laboratory values when authorized and | ||||||
15 | available; | ||||||
16 | (11) proper utilization (including over or under | ||||||
17 | utilization) and optimum therapeutic outcomes; and | ||||||
18 | (12) drug abuse and misuse. | ||||||
19 | "Medication therapy management services" includes the | ||||||
20 | following: | ||||||
21 | (1) documenting the services delivered and | ||||||
22 | communicating the information provided to patients' | ||||||
23 | prescribers within an appropriate time frame, not to exceed | ||||||
24 | 48 hours; | ||||||
25 | (2) providing patient counseling designed to enhance a | ||||||
26 | patient's understanding and the appropriate use of his or |
| |||||||
| |||||||
1 | her medications; and | ||||||
2 | (3) providing information, support services, and | ||||||
3 | resources designed to enhance a patient's adherence with | ||||||
4 | his or her prescribed therapeutic regimens.
| ||||||
5 | "Medication therapy management services" may also include | ||||||
6 | patient care functions authorized by a physician licensed to | ||||||
7 | practice medicine in all its branches for his or her identified | ||||||
8 | patient or groups of patients under specified conditions or | ||||||
9 | limitations in a standing order from the physician. | ||||||
10 | "Medication therapy management services" in a licensed | ||||||
11 | hospital may also include the following: | ||||||
12 | (1) reviewing assessments of the patient's health | ||||||
13 | status; and | ||||||
14 | (2) following protocols of a hospital pharmacy and | ||||||
15 | therapeutics committee with respect to the fulfillment of | ||||||
16 | medication orders.
| ||||||
17 | (bb) "Pharmacist care" means the provision by a pharmacist | ||||||
18 | of medication therapy management services, with or without the | ||||||
19 | dispensing of drugs or devices, intended to achieve outcomes | ||||||
20 | that improve patient health, quality of life, and comfort and | ||||||
21 | enhance patient safety.
| ||||||
22 | (cc) "Protected health information" means individually | ||||||
23 | identifiable health information that, except as otherwise | ||||||
24 | provided, is:
| ||||||
25 | (1) transmitted by electronic media; | ||||||
26 | (2) maintained in any medium set forth in the |
| |||||||
| |||||||
1 | definition of "electronic media" in the federal Health | ||||||
2 | Insurance Portability and Accountability Act; or | ||||||
3 | (3) transmitted or maintained in any other form or | ||||||
4 | medium. | ||||||
5 | "Protected health information" does not include individually | ||||||
6 | identifiable health information found in: | ||||||
7 | (1) education records covered by the federal | ||||||
8 | Family Educational Right and Privacy Act; or | ||||||
9 | (2) employment records held by a licensee in its | ||||||
10 | role as an employer. | ||||||
11 | (dd) "Standing order" means a specific order for a patient | ||||||
12 | or group of patients issued by a physician licensed to practice | ||||||
13 | medicine in all its branches in Illinois. | ||||||
14 | (ee) "Address of record" means the address recorded by the | ||||||
15 | Department in the applicant's or licensee's application file or | ||||||
16 | license file, as maintained by the Department's licensure | ||||||
17 | maintenance unit. | ||||||
18 | (ff) "Home pharmacy" means the location of a pharmacy's | ||||||
19 | primary operations.
| ||||||
20 | (Source: P.A. 94-459, eff. 1-1-06; 95-689, eff. 10-29-07.)
| ||||||
21 | (225 ILCS 85/8.5 new) | ||||||
22 | Sec. 8.5. Registration as a student pharmacist. | ||||||
23 | (a) Any person may register with the Department as a | ||||||
24 | student pharmacist if he or she provides proof that he or she | ||||||
25 | (i) is actively enrolled in a course of study for his or her |
| |||||||
| |||||||
1 | first professional degree in pharmacy at a college of pharmacy | ||||||
2 | accredited by the Accreditation Council for Pharmacy Education | ||||||
3 | (ACPE) or has graduated from such a college of pharmacy within | ||||||
4 | the past 18 months, (ii) has not engaged in conduct or behavior | ||||||
5 | determined to be grounds for discipline under this Act, and | ||||||
6 | (iii) has filed a written application for registration on a | ||||||
7 | form to be prescribed and furnished by the Department for that | ||||||
8 | purpose. | ||||||
9 | (b) The Department shall issue a certificate of | ||||||
10 | registration as a student pharmacist to any applicant who has | ||||||
11 | qualified under subsection (a) of this Section, and such | ||||||
12 | registration shall be the sole authority required to assist | ||||||
13 | licensed pharmacists in the practice of pharmacy. A student | ||||||
14 | pharmacist may, under the supervision of a pharmacist, assist | ||||||
15 | in the practice of pharmacy and perform any and all functions | ||||||
16 | delegated to him or her by the pharmacist. | ||||||
17 | The Department, upon the recommendation of the Board, may | ||||||
18 | take any action set forth in Section 30 of this Act with regard | ||||||
19 | to certificates issued by the Department pursuant to this | ||||||
20 | Section. | ||||||
21 | (c) The Department may require verification of active | ||||||
22 | enrollment of a student pharmacist applicant from his or her | ||||||
23 | college of pharmacy and may request regular enrollment updates | ||||||
24 | from colleges of pharmacy in this State and other states. | ||||||
25 | (d) Any person who is enrolled in a non-traditional | ||||||
26 | Pharm.D. program at an ACPE accredited college of pharmacy and |
| |||||||
| |||||||
1 | is a licensed pharmacist under the laws of another U.S. | ||||||
2 | jurisdiction shall be permitted to engage in the program of | ||||||
3 | practice experience required in the academic program by virtue | ||||||
4 | of such license. Such person shall be exempt from the | ||||||
5 | requirement of registration as a student pharmacist while | ||||||
6 | engaged in the program of practice experience required in the | ||||||
7 | academic program. | ||||||
8 | (e) An applicant for registration as a student pharmacist | ||||||
9 | may assist a pharmacist in the practice of pharmacy for a | ||||||
10 | period of up to 90 days prior to the issuance of a certificate | ||||||
11 | of registration if the applicant has submitted the required fee | ||||||
12 | and an application for registration to the Department. The | ||||||
13 | applicant shall keep a copy of the submitted application on the | ||||||
14 | premises where the applicant is assisting in the practice of | ||||||
15 | pharmacy. The Department shall forward confirmation of receipt | ||||||
16 | of the application with start and expiration dates of practice | ||||||
17 | pending registration.
| ||||||
18 | (225 ILCS 85/9) (from Ch. 111, par. 4129)
| ||||||
19 | (Section scheduled to be repealed on January 1, 2018)
| ||||||
20 | Sec. 9. Registration as pharmacy technician. Any person | ||||||
21 | shall be entitled
to registration as a registered pharmacy | ||||||
22 | technician who is of the age of 16
or over, has not engaged in | ||||||
23 | conduct or behavior determined to be grounds for
discipline | ||||||
24 | under this Act, is attending or has
graduated from an | ||||||
25 | accredited high school or comparable school or educational
|
| |||||||
| |||||||
1 | institution or received a GED, and has filed a written | ||||||
2 | application for registration on a form
to be prescribed and | ||||||
3 | furnished by the Department for that purpose. The
Department | ||||||
4 | shall issue a certificate of
registration as a registered | ||||||
5 | pharmacy technician to any applicant who has
qualified as | ||||||
6 | aforesaid, and such registration shall be the sole authority
| ||||||
7 | required to assist licensed pharmacists in the practice of | ||||||
8 | pharmacy, under
the supervision of a licensed pharmacist. A | ||||||
9 | registered pharmacy technician may, under the supervision of a | ||||||
10 | pharmacist, assist in the practice of pharmacy and perform such | ||||||
11 | functions as assisting in the dispensing process, offering | ||||||
12 | counseling, receiving new verbal prescription orders, and | ||||||
13 | having prescriber contact concerning prescription drug order | ||||||
14 | clarification. A registered pharmacy technician may not engage | ||||||
15 | in patient counseling, drug regimen review, or clinical | ||||||
16 | conflict resolution. | ||||||
17 | Beginning on January 1, 2010, within 2 years after being | ||||||
18 | employed as a registered technician, a pharmacy technician must | ||||||
19 | become certified by successfully passing the Pharmacy | ||||||
20 | Technician Certification Board (PTCB) examination or another | ||||||
21 | Board-approved pharmacy technician examination in order to | ||||||
22 | continue to perform pharmacy technician's duties. This | ||||||
23 | requirement does not apply to pharmacy technicians hired prior | ||||||
24 | to January 1, 2008.
| ||||||
25 | Any person registered
as a pharmacy technician who is also | ||||||
26 | enrolled in a first professional
degree program in pharmacy in |
| |||||||
| |||||||
1 | a school or college of pharmacy or a
department of pharmacy of | ||||||
2 | a university approved by the Department shall be
considered a | ||||||
3 | "pharmacy intern"
and entitled to use the title "pharmacy | ||||||
4 | intern". A pharmacy intern must meet all of the requirements | ||||||
5 | for registration as a pharmacy technician set forth in this | ||||||
6 | Section and pay the required pharmacy technician registration | ||||||
7 | fees
. | ||||||
8 | The Department, upon the recommendation of the Board, may
| ||||||
9 | take any action set forth in Section 30 of this Act with regard | ||||||
10 | to
certificates pursuant to this Section.
| ||||||
11 | Any person who is enrolled in a non-traditional Pharm.D.
| ||||||
12 | program at an ACPE accredited college of pharmacy and is a | ||||||
13 | licensed pharmacist
under the laws of another United States | ||||||
14 | jurisdiction shall be permitted to
engage in the program of | ||||||
15 | practice experience required in the academic program
by virtue | ||||||
16 | of such license. Such person shall be exempt from the | ||||||
17 | requirement
of registration as a registered pharmacy | ||||||
18 | technician while engaged in the
program of practice experience | ||||||
19 | required in the academic program.
| ||||||
20 | An applicant for registration as a pharmacy technician may | ||||||
21 | assist a
pharmacist in the practice of pharmacy for a period of | ||||||
22 | up to
60 days prior to the issuance of a certificate of | ||||||
23 | registration if the
applicant has submitted the required fee | ||||||
24 | and an application for registration
to the Department. The | ||||||
25 | applicant shall keep a copy of the submitted
application on the | ||||||
26 | premises where the applicant is assisting in the
practice of |
| |||||||
| |||||||
1 | pharmacy. The Department shall forward confirmation of receipt | ||||||
2 | of the application with start and expiration dates of practice | ||||||
3 | pending registration.
| ||||||
4 | (Source: P.A. 95-689, eff. 10-29-07.)
| ||||||
5 | (225 ILCS 85/25.15) | ||||||
6 | (Section scheduled to be repealed on January 1, 2018)
| ||||||
7 | Sec. 25.15. Telepharmacy.
| ||||||
8 | (a) In this Section, "telepharmacy" means the provision of | ||||||
9 | pharmacist care by a pharmacist that is accomplished through
| ||||||
10 | the use of telecommunications or other technologies to patients
| ||||||
11 | or their agents who are at a distance and are located within | ||||||
12 | the
United States, and which follows all federal and State | ||||||
13 | laws, rules,
and regulations with regard to privacy and | ||||||
14 | security. | ||||||
15 | (b) Any pharmacy engaged in the practice of telepharmacy | ||||||
16 | must meet all of the following conditions:
| ||||||
17 | (1) All events involving the contents of an
automated | ||||||
18 | pharmacy system must be stored in a secure location
and may | ||||||
19 | be recorded electronically. | ||||||
20 | (2) An automated pharmacy or prescription dispensing | ||||||
21 | machine system may be used in
conjunction with the | ||||||
22 | pharmacy's practice of telepharmacy after inspection and | ||||||
23 | approval by the Department. | ||||||
24 | (3) The pharmacist in charge shall: | ||||||
25 | (A) be responsible for the practice of |
| |||||||
| |||||||
1 | telepharmacy
performed at a remote pharmacy, including | ||||||
2 | the supervision of any
prescription dispensing machine | ||||||
3 | or automated medication system; | ||||||
4 | (B) ensure that the home pharmacy has
sufficient | ||||||
5 | pharmacists on duty for the safe operation and
| ||||||
6 | supervision of all remote pharmacies; | ||||||
7 | (C) ensure, through the use of a video and auditory
| ||||||
8 | communication system, that a certified pharmacy | ||||||
9 | technician at the remote
pharmacy has accurately and | ||||||
10 | correctly prepared any prescription for
dispensing | ||||||
11 | according to the prescription; | ||||||
12 | (D) be responsible for the supervision and | ||||||
13 | training of
certified pharmacy technicians at remote | ||||||
14 | pharmacies who shall be subject to
all rules and | ||||||
15 | regulations; and | ||||||
16 | (E) ensure that patient counseling at the remote | ||||||
17 | pharmacy is
performed by a pharmacist or student | ||||||
18 | pharmacist pharmacist intern .
| ||||||
19 | (Source: P.A. 95-689, eff. 10-29-07.)
| ||||||
20 | Section 99. Effective date. This Act takes effect on | ||||||
21 | December 31, 2009.
|